Ads
related to: intranasal
Search results
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple...
Morningstar· 45 minutes ago- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) ...
atai Life Sciences reports positive Phase 1 results for BPL-003 By Investing.com
Investing.com· 2 days agoNEW YORK - atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on...
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting...
Morningstar· 1 day agoNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies ...
What Is Allergic Rhinitis?
Health via Yahoo News· 3 days agoMedications Several over-the-counter (OTC) and prescription medications effectively reduce allergic rhinitis symptoms. These include: Nasal steroid...
IV Ketamine Promising for Refractory Headache in Kids
Medscape· 3 days agoIntravenous (IV) ketamine is an effective and safe treatment option for children with severe refractory headache, new research suggests. In a retrospective chart review, IV ketamine led to in ...
Opioid Deaths Doubled Across Canada After Pandemic Onset
Medscape· 2 days agoPremature opioid-related deaths doubled in Canada after the onset of COVID-19 pandemic, and more...
atai announces publication of Beckley Psytech's Phase 1 study for novel 5-MeO-DMT asset
Proactive Investors· 2 days agoPsychedelic effects occurred within minutes and were resolved in less than two hours which atai...
Equities Analysts Offer Predictions for Amphastar Pharmaceuticals, Inc.’s Q1 2024 Earnings...
ETF DAILY NEWS· 1 day agoAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) – Equities researchers at Capital One Financial issued their Q1 2024 earnings per share estimates for shares of Amphastar Pharmaceuticals ...
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Insider Sarina Tanimoto Sells 100,000 Shares
ETF DAILY NEWS· 1 day agoARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 100,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 16th. The shares were ...
Mutual of America Capital Management LLC Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc....
ETF DAILY NEWS· 4 days agoMutual of America Capital Management LLC reduced its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.2% in the 4th quarter, according to the company in ...
